National Research Nuclear University MEPhI, Russia
Sechenov University & National Research Nuclear University MEPhI, Russia
Dear Colleagues, Partners, Scientists, Clinicians, Bioengineers and Friends,
Advances in fundamental, translational and clinical research as well as in environmental sciences and the availability of biomarkers are beginning to transform the healthcare landscape. Biomarker platforms construe the work that goes into bringing the most promising experimental therapies, diagnostic and monitoring technologies to the clinic after extensive testing in experimental models and being validated.
In this context, we at I.M.Sechenov First Moscow State Medical University and Moscow Engineering Physical Institute (MEPhI) jointly with the United Scientific Group (URG) hosting the Conference, look forward to welcoming you to the fantastic International Conference on Biomarker Research in Clinical Medicine, to be held in the City of Par-is. The meeting planned would bring in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its Translational and Clinical impacts. The conference will provide a forum for researchers, clinicians and drug designers to present cutting edge re-search and learn about the latest breakthroughs and technologies in biomarker-related areas.
The Conference will provide the ideal forum to stimulate ideas and establish collaborations as well as to initiate intense discussions. The Program will discuss how biomarkers can be used to improve drug discovery and development and to treat disease, and how it is helping to centralize and organize medical knowledge. The Conference will also include a Satellite Symposium on Educational Aspects and on how to apply biomarkers in the daily clinical practice, with insights from entrepreneurs who have made the transition from academic-based translational research to the clinical and industrial sector.
At the gathering, we hope to build on the conventional approach to biomarker-aided strategy by fostering a method in which practitioners undertake a comprehensive evaluation of Biomarker Impact while accounting for information such as genomic, proteomic, metabolomics and related biomarker platforms through the use of the newest analytical technologies. Our goal is to open a forum to facilitate the exchange of knowledge and experience and to invigorate the field with young clinicians and scientists. The Conference would secure the attracted participation from many of established leaders as well to open a green light for concentrating focus on generating solutions to the field’s challenges. The latter would propose ways to encourage investment in innovation and stimulate the adoption of personalized and translational medicine in the daily practice.
In keeping with the theme, we have collaborated with the United Scientific Group (URG) and National Alliance on Translational Medicine (NATM) partners in Russia and our colleagues from different parts of the Globe to hold an additional program off-site and plans and programs to be added to the Program. We are delighted to assist the Organizers in order to foster and promote excellence in biomarker-related discussions as well as to secure leadership in promoting Research, Clinical, Industrial and Educational development of this field. And the Conference will bring together scientists and entrepreneurs who are interested in biomarker-related future and research to be implemented into healthcare tools and biopharma services.
We look forward to seeing you at the Meeting, and to providing you with an unforgettable scientific and social experience in Paris which whilst being the global capital for elegant sophistication and thus the emotional and cultural capital of the world is also a place where many different cultures, brilliant academic science and clinical experience, artistic excellence and sophisticated tastes meet in interesting and fascinating ways.
Personally we are convinced that the international partnership and collaboration would play a crucial promoting role for the jointly set projects from any points of view. We do hope that your interaction with your colleagues from many different countries will stimulate a creative ex-change of ideas and will be personally rewarding.